The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXtract Regulatory News (XTR)

Share Price Information for Xtract (XTR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.00
Bid: 0.90
Ask: 1.10
Change: 0.00 (0.00%)
Spread: 0.20 (22.222%)
Open: 1.00
High: 1.00
Low: 1.00
Prev. Close: 1.00
XTR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

30 Sep 2020 07:05

RNS Number : 5142A
Xtract Resources plc
30 September 2020
 

 

 

For immediate release

30 September 2020

 

Xtract Resources Plc

("Xtract" or the "Company")

Placing

Total Voting Rights

 

Placing

The Board of Xtract Resources Plc ("Xtract" or the "Company") announces that the Company's Broker, Novum Securities, has today conditionally raised £650,000 (before expenses) following the placement of 54,666,666 new Ordinary Shares of 0.02p each ("Ordinary Shares") at 1.20p ("Placing Price") per new Ordinary Share (the "Placing"). The new Ordinary Shares represent 11.84% of the current issued ordinary share capital of the Company. The Placing Price is at a discount of approximately 6% compared to the 5-day volume weighted average price of 1.27p for the period ended 28 September 2020. In completing the Placing, the Board has utilised the share authorities approved by shareholders at the last Annual General Meeting.

 

The net proceeds from the Placing will be utilised by the Company to fund the further development of its exploration and development projects in Australia and in Zambia and provide additional working capital.

 

Colin Bird, Executive Chairman said: "This placing will assist the Company to advance its various projects in Zambia and Australia. The Manica cash flow is expected to increase in the fourth quarter as the free milling gold initiatives begin to contribute to cash flow. Additionally, during the fourth quarter the Company will commence definition drilling in Eureka and pit extension drilling in Kalengwa. The Company is considering other means of combating the effect of the COVID-19 border restrictions in Mozambique and South Africa and will keep the market informed."

 

Warrants

In conjunction with the placing, the Company will issue the placees a total of 27,083,333 warrants, being half a warrant for every share. The warrants are exercisable in whole or in part at 1.85p per new Ordinary Share to be exercised within 2 years of being issued.

 

In conjunction with the Placing, the Company will issue the Broker 3,250,000 warrants, exercisable in whole or in part at 1.20p per new Ordinary Share within 2 years of being issued.

 

A total 1,250,000 new Ordinary Shares will be issued at the placing price of 1.20p in lieu of fees ("Fee Shares").

 

Further AIM and other Disclosures

Sanderson Capital Partners ("Sanderson") has subscribed £250,000 pursuant to the Placing. On 4 September 2019, the Company published a TR-1 provided by Sanderson in which Sanderson disclosed an interest in Xtract of 14.199%. While the Company understands that Sanderson subsequently reduced its holding in Xtract to below 10%, the Company has for the purposes of the proposed subscription pursuant to the Placing, treated Sanderson as a related party for the purposes of AIM Rule 13 as a substantial shareholder within the prior 12 month period. The Directors of Xtract consider, having consulted with the Company's Nominated Adviser, that Sanderson's participation in the Placing is fair and reasonable insofar as Xtract's shareholders are concerned. The Directors have noted in particular that Sanderson have participated in the Placing by the Company's Broker on the same terms and conditions as the other placees.

 

The Company has also agreed to settle a corporate creditor through the issuance 1,250,000 new ordinary shares at an issue price of 1.20p per ordinary share (equivalent to fees of £15,000) ("Settlement Shares").

 

Admission to AIM

Application will be made for admission of the Placing Shares, the Fee Shares and the Settlement Shares ("New Shares"), in aggregate amounting to 56,666,666 new Ordinary Shares, to trading on AIM ("Admission") on or around 28 October 2020. The New Shares will rank pari passu in all respects with the Company's existing issued ordinary shares.

 

Total Voting Rights

On Admission of the New Shares, the Company will have 513,969,954 Ordinary Shares in issue with voting rights. Xtract does not currently hold any shares in treasury. Accordingly, this figure of 513,969,954 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Further details are available from the Company's website which details the company's project portfolio as well as a copy of this announcement: www.xtractresources.com 

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation No. 596/2014 on market abuse. The person who arranged for the release of this announcement on behalf of the Company was Colin Bird, Director.

 

Enquiries:

 

Xtract Resources Plc

Colin Bird,

Executive Chairman

 

+44 (0)20 3416 6471

www.xtractresources.com

Beaumont Cornish Limited

Nominated Adviser and Joint Broker

Roland Cornish

Michael Cornish

Felicity Geidt

+44 (0)207628 3396

www.beaumontcornish.co.uk

 

Novum Securities Limited

Joint Broker

 

Colin Rowbury

 

+44 (0)207 399 9427

www.novumsecurities.com  

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEFKLLLBKLEBBB
Date   Source Headline
3rd Apr 20241:00 pmRNSZambian Exploration Licence Joint Venture
23rd Feb 20249:00 amRNSCompletion of Disposal of Manica Gold Project
16th Feb 20249:05 amRNSDisposal of Manica Gold Project
13th Feb 20241:15 pmRNSResult of Meeting
8th Feb 20247:00 amRNSUpdate on Zambian Copper Joint Venture & Strategy
24th Jan 202411:00 amRNSProposed disposal of Manica Gold Project
6th Nov 202311:30 amRNSBushranger pit optimisation & financial study
23rd Oct 20231:32 pmRNSManica Q2 2023 Gold Production Update
29th Sep 202311:10 amRNSHalf-year Report
24th Aug 20239:24 amRNSZambian exploration licences joint venture
28th Jul 20236:00 pmRNSResult of AGM
20th Jul 20239:05 amRNSBushranger Pre-Concentration Test Results
6th Jul 20237:00 amRNSManica Q1 2023 Gold Production Update
5th Jul 202310:28 amRNSNotice of AGM
29th Jun 20234:16 pmRNSFinal Results
20th Jun 202312:55 pmRNSAccounts and Annual General Meeting update
6th Apr 20237:00 amRNSFourth quarter 2022 production update
30th Mar 20237:00 amRNSChange of auditor
7th Mar 20234:35 pmRNSPrice Monitoring Extension
7th Mar 20237:00 amRNSUpdate on Open Pit Mining Study for Bushranger
26th Jan 20237:00 amRNSKakuyu Copper Project Zambia update
23rd Jan 20234:40 pmRNSSecond Price Monitoring Extn
23rd Jan 20234:35 pmRNSPrice Monitoring Extension
13th Jan 20239:44 amRNSDirector/PDMR Shareholding
9th Jan 20231:25 pmRNSThird quarter 2022 production update
19th Dec 202211:42 amRNSAscot Prospect Maiden Mineral Resource
15th Dec 20223:53 pmRNSKakuyu copper project Zambia
8th Dec 20224:08 pmRNSHolding(s) in Company
5th Dec 202210:32 amRNSTotal Voting Rights
23rd Nov 202211:05 amRNSSecond Price Monitoring Extn
23rd Nov 202211:00 amRNSPrice Monitoring Extension
23rd Nov 20227:00 amRNSRacecourse Prospect Updated Mineral Resource
22nd Nov 202212:21 pmRNSApplication update
4th Nov 202210:43 amRNSAward of share options and settlement shares
6th Oct 202211:00 amRNSAscot Prospect final assay results
30th Sep 202210:52 amRNSHalf-year Report
30th Sep 20227:00 amRNSProduction update
24th Aug 202210:20 amRNSResult of AGM
15th Aug 20221:05 pmRNSBushranger results of metallurgical test work
8th Aug 20224:40 pmRNSSecond Price Monitoring Extn
8th Aug 20224:35 pmRNSPrice Monitoring Extension
8th Aug 20222:06 pmRNSSecond Price Monitoring Extn
8th Aug 20222:00 pmRNSPrice Monitoring Extension
4th Aug 20229:13 amRNSBushranger completion of phase two drilling
29th Jul 202211:37 amRNSNotice of AGM
27th Jul 202212:14 pmRNSBushranger assay results and drilling update
21st Jul 20227:00 amRNSFair Bride Update
7th Jul 202212:18 pmRNSBushranger assay results and drilling update
1st Jul 202211:06 amRNSSecond Price Monitoring Extn
1st Jul 202211:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.